Literature DB >> 11280802

EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

D P Zelinski1, N D Zantek, J C Stewart, A R Irizarry, M S Kinch.   

Abstract

Elevated levels of protein tyrosine phosphorylation contribute to a malignant phenotype, although the tyrosine kinases that are responsible for this signaling remain largely unknown. Here we report increased levels of the EphA2 (ECK) protein tyrosine kinase in clinical specimens and cell models of breast cancer. We also show that EphA2 overexpression is sufficient to confer malignant transformation and tumorigenic potential on nontransformed (MCF-10A) mammary epithelial cells. The transforming capacity of EphA2 is related to the failure of EphA2 to interact with its cell-attached ligands. Interestingly, stimulation of EphA2 reverses the malignant growth and invasiveness of EphA2-transformed cells. Taken together, these results identify EphA2 as a powerful oncoprotein in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280802

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  194 in total

1.  A role for epha2 in cell migration and refractive organization of the ocular lens.

Authors:  Yanrong Shi; Alicia De Maria; Thomas Bennett; Alan Shiels; Steven Bassnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

2.  Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening.

Authors:  Kristoff T Homan; Deepa Balasubramaniam; Adam P R Zabell; Olaf Wiest; Paul Helquist; Cynthia V Stauffacher
Journal:  Bioorg Med Chem       Date:  2010-04-21       Impact factor: 3.641

Review 3.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

Review 4.  Eph and ephrin signaling in mammary gland morphogenesis and cancer.

Authors:  Anne-Catherine Andres; Andrew Ziemiecki
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

5.  Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.

Authors:  Yong Liu; Changyun Yu; Yuanzheng Qiu; Donghai Huang; Xiaojuan Zhou; Xin Zhang; Yongquan Tian
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-16       Impact factor: 4.553

6.  EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.

Authors:  Arend H Sikkema; Wilfred F A den Dunnen; Esther Hulleman; Dannis G van Vuurden; Guillermo Garcia-Manero; Hui Yang; Frank J G Scherpen; Kim R Kampen; Eelco W Hoving; Willem A Kamps; Sander H Diks; Maikel P Peppelenbosch; Eveline S J M de Bont
Journal:  Neuro Oncol       Date:  2012-06-21       Impact factor: 12.300

7.  Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression.

Authors:  Justin M Drake; Nicholas A Graham; Tanya Stoyanova; Amir Sedghi; Andrew S Goldstein; Houjian Cai; Daniel A Smith; Hong Zhang; Evangelia Komisopoulou; Jiaoti Huang; Thomas G Graeber; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

8.  Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.

Authors:  Haifa Shen; Cristian Rodriguez-Aguayo; Rong Xu; Vianey Gonzalez-Villasana; Junhua Mai; Yi Huang; Guodong Zhang; Xiaojing Guo; Litao Bai; Guoting Qin; Xiaoyong Deng; Qingpo Li; Donald R Erm; Burcu Aslan; Xuewu Liu; Jason Sakamoto; Arturo Chavez-Reyes; Hee-Dong Han; Anil K Sood; Mauro Ferrari; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2013-02-05       Impact factor: 12.531

9.  Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Lijuan Wang; Wenyi Wei; Agnes B Kane; Y Eugene Chin
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 10.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.